Syneos Health (SYNH) Now Covered by Mitsubishi UFJ Financial Group

Mitsubishi UFJ Financial Group assumed coverage on shares of Syneos Health (NASDAQ:SYNH) in a report issued on Friday morning. The firm issued an overweight rating and a $50.00 price objective on the stock.

Other equities research analysts also recently issued research reports about the company. Robert W. Baird set a $50.00 price target on Syneos Health and gave the company a buy rating in a research report on Thursday, February 22nd. Zacks Investment Research raised Syneos Health from a hold rating to a buy rating and set a $41.00 price objective on the stock in a research note on Tuesday, February 13th. Credit Suisse Group reaffirmed a buy rating and set a $52.00 price objective on shares of Syneos Health in a research note on Thursday, January 4th. KeyCorp reaffirmed a buy rating and set a $50.00 price objective on shares of Syneos Health in a research note on Thursday, January 4th. Finally, BidaskClub raised Syneos Health from a hold rating to a buy rating in a research note on Wednesday, January 3rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the stock. The company has an average rating of Buy and an average target price of $49.80.

How to Become a New Pot Stock Millionaire

NASDAQ SYNH opened at $38.20 on Friday. Syneos Health has a twelve month low of $31.10 and a twelve month high of $61.10. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 0.98. The stock has a market cap of $3,918.59, a price-to-earnings ratio of 19.69, a PEG ratio of 0.95 and a beta of 0.80.

Syneos Health (NASDAQ:SYNH) last released its quarterly earnings results on Wednesday, February 28th. The company reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.15. Syneos Health had a positive return on equity of 10.78% and a negative net margin of 5.18%. The business had revenue of $750.47 million for the quarter, compared to the consensus estimate of $757.94 million. analysts predict that Syneos Health will post 2.28 EPS for the current fiscal year.

Several large investors have recently made changes to their positions in SYNH. Globeflex Capital L P bought a new stake in shares of Syneos Health in the fourth quarter worth about $210,000. Municipal Employees Retirement System of Michigan bought a new stake in shares of Syneos Health in the fourth quarter worth about $741,000. Finally, Geode Capital Management LLC bought a new stake in shares of Syneos Health in the fourth quarter worth about $23,570,000.

COPYRIGHT VIOLATION WARNING: This report was first reported by Week Herald and is the sole property of of Week Herald. If you are reading this report on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The original version of this report can be viewed at https://weekherald.com/2018/04/24/syneos-health-synh-now-covered-by-mitsubishi-ufj-financial-group.html.

Syneos Health Company Profile

Syneos Health, Inc operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as unbundled service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process.

Analyst Recommendations for Syneos Health (NASDAQ:SYNH)

Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply